دورية أكاديمية

Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study

التفاصيل البيبلوغرافية
العنوان: Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study
المؤلفون: Amraee, A., Evazi, M. R., Shakeri, M., Roozbeh, N., Ghazanfarpour, M., Ghorbani, M., Ansari, J., Darvish, L.Aff4, Aff8, IDs12094018020324_cor8
المصدر: Clinical and Translational Oncology. 21(8):1093-1103
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:1699048X
16993055
DOI:10.1007/s12094-018-02032-4